mitoxantrone ( 1,4-dihydroxy-5,8-bis [ 2- [ ( 2-hydroxyethyl ) amino ] ethyl ) amino ) -9 , 10 anthracenedione dihydrochloride , nsc 301,739 ) is a new aminoanthraquinone derivative with clinical activity in the treatment of advanced breast cancer ( 1 , 2 ) , lymphoma ( 3 ) , and acute leukemia ( 4 ) .
C0026259
mitoxantrone
C0003174
anthracenedione